|
 |  |  | | |  | Scientific publications dedicated to their products |
| 500600 - Leptin EIA Kit 512011 - Prostaglandin D2-MOX EIA kit 514010 - Prostaglandin E2 EIA kit 514012 - Prostaglandin Screening EIA kit 514131 - STAT-Prostaglandin E2 EIA kit 514531 - Bicyclo Prostaglandin E2 EIA kit 515211 - 6-keto-Prostaglandin F1α EIA kit 516011 - Prostaglandin F2α EIA kit 516351 - 8-Isoprostane EIA kit 516521 - 11β-Prostaglandin F2α EIA kit 519031 - Thromboxane B2 EIA kit 519051 - 2,3-dinor Thromboxane B2 EIA kit 519501 - 11-dehydro Thromboxane B2 EIA kit 520111 - Leukotriene B4 EIA kit 520211 - Leukotriene C4 EIA kit 520411 - Leukotriene E4 EIA kit 520501 - Cysteinyl-Leukotriene EIA kit 560101 - COX Inhibitor Screening Assay 581001 - Cyclic AMP EIA kit 581021 - Cyclic GMP EIA kit 582251 - Estradiol EIA kit 582601 - Progesterone EIA kit 582701 - Testosterone EIA kit 583151 - Endothelin-1 EIA kit 583301 - Human Interleukin-1αEIA kit 583311 - Human Interleukin-1βIA kit 583321 - Human Interleukin-2 EIA kit 583341 - Human Interleukin-4 EIA kit 583361 - Human Interleukin-6 EIA kit 583751 - Substance P EIA kit 585000 - sPLA2 (human synovial) EIA kit 589201 - TNF-α(human) EIA kit 660951 - cDNA Synthesis kit 703002 - Glutathione Assay kit 705002 - Lipid Hydroperoxide (LPO) Assay kit 760700 - Lipoxygenase Inhibitor Screening Assay kit 760871 - Nitrate/Nitrite Colorimetric Assay Kit (LDH method) 760901 - PAF Acetylhydrolase Assay kit 765001 - sPhospholipase A2 Assay kit 765021 - Cytosolic Phospholipase A2 Assay kit 780001 - Nitrate/Nitrite Colorimetric Assay kit 780051 - Nitrate/Nitrite Fluorimetric Assay kit 781001 - NOS Assay kit
|  | | 500600 - Leptin EIA Kit |  | | | ZHANG Y., PROENCA R., MAFFEI M. & al. | | | Positional cloning of the mouse obese gene and its human homologue. Nature. 372, 425-432 (1994). |
|  | | | CONSIDINE R., SINHA M., HEIMAN M. & al. | | | Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Eng. J. Med. 334, 292-295 (1995). |
|  | | | HALAAS J-L., GAJUWALA K.S., MAFFEI M. & al. | | | Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269, 543-546 (1995). |
|  | | | PELLEYMOUNTER M.A., CULLEN M., BAKER M-J. & al. | | | Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269, 540-543 (1995). |
|  | | | CONSIDINE R-V., CONSIDINE E-L. WILLIAMS C-J. & al. | | | Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J. Clin. Invest. 95, 2986-2988 (1995). |
|  | | | CONSIDINE R-V., CONSIDINE E-L., WILLIAMS C-J. & al. | | | Mutation screening and identification of a sequence variation in the human ob gene coding region. Biochem. Biophys. Res. Commun. 220, 735-739 (1996). |
| | [top] |  |
| | 512011 - Prostaglandin D2-MOX EIA kit |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | KELLY R-W., DEAM S., CAMERON M-J. & SEAMARK R-F. | | | Measurement by Radioimmunoassay of Prostaglandins as their Methyl Oximes. Prostaglandins Leukotrienes and Medicine. 24, 1-14 (1986). |
|  | | | FARMAN N., PRADELLES Ph. & BONVALET J-P. | | | PGE2, PGF2a, 6-keto-PGF1a and TXB2 synthesis along the rabbit nephron. Am. J. Physiol. 252, F53-F59 (1987). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 514010 - Prostaglandin E2 EIA kit |  | | | HAMBERG M. & SAMUELSSON B. | | | On the metabolism of prostaglandins E1 and E2 in man. J. Biol. Chem. 246, 6713-6721 (1971). |
|  | | | GRANSTRÖM E., HAMBERG M., HANSSON G. & al. | | | Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability. Prostaglandins. 19, 933-945 (1980). |
|  | | | FITZPATRICK F-A., AGUIRRE R., PIKE J-E. & al. | | | The stability of 13,14-dihydro-15-keto-PGE2. Prostaglandins. 19, 917-931 (1980). |
|  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 514012 - Prostaglandin Screening EIA kit |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 514131 - STAT-Prostaglandin E2 EIA kit |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 514531 - Bicyclo Prostaglandin E2 EIA kit |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
| | [top] |  |
| | 515211 - 6-keto-Prostaglandin F1α EIA kit |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | WESTCOTT J. et al. | | | Analysis of 6-keto-PGF1α, 5-HETE, and LTC4 in rat lung: Comparison of GC/MS, RIA and EIA. Prostaglandins. 32 857-873 (1986). |
|  | | | FARMAN N., PRADELLES Ph. & BONVALET J-P. | | | PGE2, PGF2α, 6-keto-PGF1α and TXB2 synthesis along the rabbit nephron. Am. J. Physiol. 252, F53-F59 (1987). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 516011 - Prostaglandin F2α EIA kit |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | FARMAN N., PRADELLES Ph. & BONVALET J-P. | | | PGE2, PGF2a, 6-keto-PGF1a and TXB2 synthesis along the rabbit nephron. Am. J. Physiol. 252, F53-F59 (1987). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 516351 - 8-Isoprostane EIA kit |  | | | BLIGH E-G. & DYER W-J. | | | Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Can. J. Biochem. Physiol. 37, 911-917 (1959). |
|  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | MORROW J.D., HILL K-E., BURK R-F. et al. | | | A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 87, 9383-9387 (1990). |
|  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholinesterase. Methods Enzymol. 187, 24-34 (1990). |
|  | | | MORROW J-D., HARRIS T-M. & ROBERTS II L-J. | | | Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184, 1-10 (1990) |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
|  | | | BANERJEE M., KANG K-H., MORROW, J-D. et al. | | | Effects of a novel prostaglandin, 8-epi-PGF2α, in rabbit lung in situ. Am. J. Physiol. 263, H660-H663 (1992). |
|  | | | VACCHIANO C-A. & TEMPEL G-E. | | | Role of nonenzymatically generated prostanoid, 8-iso-PGF2α, in pulmonary oxygen toxicity. J. Appl. Physiol. 77 2912-2917 (1994). |
|  | | | MORROW J-D., FERI B., LONGMIRE A-W., et al. | | | Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N. Eng. J. Med. 332, 1198-1203 (1995). |
| | [top] |  |
| | 516521 - 11β-Prostaglandin F2α EIA kit |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 519031 - Thromboxane B2 EIA kit |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | WESTCOTT J. et al. | | | Analysis of 6-keto-PGF1α, 5-HETE, and LTC4 in rat lung: Comparison of GC/MS, RIA and EIA. Prostaglandins. 32 857-873 (1986). |
|  | | | FARMAN N., PRADELLES Ph. & BONVALET J-P. | | | PGE2, PGF2α, 6-keto-PGF1α and TXB2 synthesis along the rabbit nephron. Am. J. Physiol. 252, F53-F59 (1987). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | PRADELLES Ph. et al. | | | Development of enzyme immunoassays for leukotrienes C4 and E4 using acetylcholinesterase. Methods Enzymol. 187, 82-89 (1990). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 519051 - 2,3-dinor Thromboxane B2 EIA kit |  | | | HAMBER, M., SVENSSO, J. & SAMUELSSON B. | | | Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. USA 72, 2994-2998 (1975). |
|  | | | SAMUELSSON B., GRANSTRÖM E., GREEN K. et al. | | | Prostaglandins. Ann. Rev. Biochem. 44, 669-695 (1975). |
|  | | | ELLIS E-F., OELZ O., ROBERTS L-J. et al. | | | Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science. 193, 1135-1137 (1976). |
|  | | | SALZMAN P-M., SALMON J-A. & MONCADA S. | | | Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery. J. Pharmacol. Exp. Ther. 215, 240-247 (1980). |
|  | | | ROBERTS L-J., SWEETMAN B-J. & OATES J-A. | | | Metabolism of thromboxane B2 in man. J. Biol. Chem. 256, 8384-8393 (1981). |
|  | | | PATRON, C., CIABATTON, G., PUGLIES, F. et al. | | | Estimated rate of thromboxane secretion into the circulation of normal human. J. Clin. Invest. 77, 590-594 (1986). |
|  | | | LAWSON J-A., PATRONO C., CIABATTONI G. et al. | | | Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal. Biochem. 155, 198-205 (1986). |
|  | | | LELLOUCHE F., FRADIN A., FITZGERALD G. et al. | | | Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin. Prostaglandins. 40, 297-309 (1990). |
| | [top] |  |  | | 519501 - 11-dehydro Thromboxane B2 EIA kit |  | | | HAMBER, M., SVENSSO, J. & SAMUELSSON B. | | | Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. USA 72, 2994-2998 (1975). |
|  | | | SAMUELSSON B., GRANSTRÖM E., GREEN K. et al. | | | Prostaglandins. Ann. Rev. Biochem. 44, 669-695 (1975). |
|  | | | ELLIS E-F., OELZ O., ROBERTS L-J. et al. | | | Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science. 193, 1135-1137 (1976). |
|  | | | SALZMAN P-M., SALMON J-A. & MONCADA S. | | | Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery. J. Pharmacol. Exp. Ther. 215, 240-247 (1980). |
|  | | | ROBERTS L-J., SWEETMAN B-J. & OATES J-A. | | | Metabolism of thromboxane B2 in man. J. Biol. Chem. 256, 8384-8393 (1981). |
|  | | | CATELLA F., HEALY D., LAWSON J-A. et al. | | | 11-dehydro thromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. Proc. Natl. Acad. Sci. USA 83, 5861-5865 (1986). |
|  | | | PATRON, C., CIABATTON, G., PUGLIES, F. et al. | | | Estimated rate of thromboxane secretion into the circulation of normal human. J. Clin. Invest. 77, 590-594 (1986). |
|  | | | LAWSON J-A., PATRONO C., CIABATTONI G. et al. | | | Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal. Biochem. 155, 198-205 (1986). |
|  | | | CIABATTONI G., PUGLIESE F., DAVI G. et al. | | | Fractional conversion of thromboxane B2 to urinary 11-dehydro thromboxane B2 in man. Biochim. Biophys. Acta 992, 66-70 (1989). |
|  | | | LELLOUCHE F., FRADIN A., FITZGERALD G. et al. | | | Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin. Prostaglandins. 40, 297-309 (1990). |
| | [top] |  |
|  | | 520111 - Leukotriene B4 EIA kit |  | | | WESTCOTT J. et al. | | | Analysis of 6-keto-PGF1α, 5-HETE, and LTC4 in rat lung: Comparison of GC/MS, RIA and EIA. Prostaglandins. 32 857-873 (1986). |
|  | | | FARMAN N., PRADELLES Ph. & BONVALET J-P. | | | PGE2, PGF2α 6-keto-PGF1αand TXB2 synthesis along the rabbit nephron. Am. J. Physiol. 252, F53-F59 (1987). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | PRADELLES Ph. et al. | | | Development of enzyme immunoassays for leukotrienes C4 and E4 using acetylcholinesterase. Methods Enzymol. 187, 82-89 (1990). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
|
| | 520211 - Leukotriene C4 EIA kit |  | | | WESTCOTT J. et al. | | | Analysis of 6-keto-PGF1α, 5-HETE, and LTC4 in rat lung: Comparison of GC/MS, RIA and EIA. Prostaglandins. 32 857-873 (1986). |
|  | | | FARMAN N., PRADELLES Ph. & BONVALET J-P. | | | PGE2, PGF2α, 6-keto-PGF1α and TXB2 synthesis along the rabbit nephron. Am. J. Physiol. 252, F53-F59 (1987). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | PRADELLES Ph. et al. | | | Development of enzyme immunoassays for leukotrienes C4 and E4 using acetylcholinesterase. Methods Enzymol. 187, 82-89 (1990). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 520411 - Leukotriene E4 EIA kit |  | | | WESTCOTT J. et al. | | | Analysis of 6-keto-PGF1α, 5-HETE, and LTC4 in rat lung: Comparison of GC/MS, RIA and EIA. Prostaglandins. 32 857-873 (1986). |
|  | | | FARMAN N., PRADELLES Ph. & BONVALET J-P. | | | PGE2, PGF2α, 6-keto-PGF1α and TXB2 synthesis along the rabbit nephron. Am. J. Physiol. 252, F53-F59 (1987). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | PRADELLES Ph. et al. | | | Development of enzyme immunoassays for leukotrienes C4 and E4 using acetylcholinesterase. Methods Enzymol. 187, 82-89 (1990). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 520501 - Cysteinyl-Leukotriene EIA kit |  | | | DAHLÉN S-E, BJÖRK J., HEDQVIST P. et al. | | | Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 78, 3887-3891 (1981). |
|  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | POWELL W.S | | | Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenases. Anal. Biochem. 148, 59-69 (1985). |
|  | | | SAMUELSSON B., DAHLÉN S-E., LINDGREN J-A. et al. | | | Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science. 237, 1171-1176 (1987). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | PIPER P-J. | | | Formation and actions of leukotrienes. Physiol. Rev. 64, 744-761 (1990). |
|  | | | CAMPBELL B-J., BAKER S-F., SHUKLA S-D. et al. | | | Bioconversion of leukotriene D4 by lung dipeptidase. Biochim. Biophys. Acta 1042, 6107-112 (1990). |
|  | | | WESCOTT J-Y., JOHNSTON K., BATT R-A. et al. | | | Measurement of peptido-leukotrienes in biological fluids. Am. J. Physiol. 232, 2640-2648 (1990). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
|  | | | MATSUMOTO S., HAYASHI Y., KINOSHITA I. et al. | | | Immunoaffinity purification of prostaglandin E2 and leukotriene C4 prior to radioimmunoassay: application to human synovial fluid. Ann. Clin. Biochem. 30 (Part I), 60-68 (1993). |
| | [top] |  |
| | 560101 - COX Inhibitor Screening Assay |  | | | PRADELLES Ph., GRASSI. J. & MACLOUF J. | | | Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to Radioimmunoassay. Anal. Chem. 57 1170-1173 (1985). |
|  | | | MACLOU J., GRASSI J. & PRADELLES Ph. | | | Development of enzyme-immunoassay techniques for the measurement of eicosanoids. Prostaglandins and Lipid Metabolism in Radiation Injury. 355-364 (1987). |
|  | | | XIE W., CHIPMAN J-G., ROBERTSON D-L. et al. | | | Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA, 88, 2692-2696 (1991). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 581001 - Cyclic AMP EIA kit |  | | | PRADELLES Ph. & GRASSI J. | | | Enzyme Immunoassays of Adenosine cyclic 3',5'-Monophosphate and Guanosine cyclic 3',5'-Monophosphate using Acetylcholinesterase. Anal. Chem. 61, 447 (1989). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 581021 - Cyclic GMP EIA kit |  | | | XIE W., CHIPMAN J-G., ROBERTSON D-L. et al. | | | Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. USA, 88, 2692-2696 (1991). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 582251 - Estradiol EIA kit |  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 582601 - Progesterone EIA kit |  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 582701 - Testosterone EIA kit |  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 583151 - Endothelin-1 EIA kit |  | | | YANAGISAWA M. et al. | | | A novel potent vasoconstrictor peptide produced by vascular endothelium cells. Nature. 332, 411 (1988). |
|  | | | LOVENBERG W. & MILLER R-C. | | | Endothelin: a review of its effects and possible mechanisms of action. Neurochem. Res. 15, 407 (1990). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 583301 - Human Interleukin-1αEIA kit |  | | | DURUM S-K., SCHMIDT J-A. & OPPENHEIM J-J. | | | Interleukin 1: an immunological perspective. Ann. Rev. Immunol. 3, 263-287 (1985). |
|  | | | OPPENHEIM J-J. et al. | | | There is more than one Interleukin 1. Immunology Today. 7.2, 46-56 (1986). |
|  | | | GRASSI J., ROBERGE C-J., FROBERT Y. et al. | | | Determination of IL1α, IL1β and IL2 in biological media using specific enzyme immunometric assays. Immunol. Rev. 119, 125-145 (1991). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 583311 - Human Interleukin-1βIA kit |  | | | DURUM S-K., SCHMIDT J-A. & OPPENHEIM J-J. | | | Interleukin 1: an immunological perspective. Ann. Rev. Immunol. 3, 263-287 (1985). |
|  | | | OPPENHEIM J-J. et al. | | | There is more than one Interleukin 1. Immunology Today. 7.2, 46-56 (1986). |
|  | | | GRASSI J., ROBERGE C-J., FROBERT Y. et al. | | | Determination of IL1α, IL1β and IL2 in biological media using specific enzyme immunometric assays. Immunol. Rev. 119, 125-145 (1991). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 583321 - Human Interleukin-2 EIA kit |  | | | DURUM S-K., SCHMIDT J-A. & OPPENHEIM J-J. | | | Interleukin 1: an immunological perspective. Ann. Rev. Immunol. 3, 263-287 (1985). |
|  | | | OPPENHEIM J-J. et al. | | | There is more than one Interleukin 1. Immunology Today. 7.2, 46-56 (1986). |
|  | | | GRASSI J., ROBERGE C-J., FROBERT Y. et al. | | | Determination of IL1α, IL1β and IL2 in biological media using specific enzyme immunometric assays. Immunol. Rev. 119, 125-145 (1991). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 583341 - Human Interleukin-4 EIA kit |  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 583361 - Human Interleukin-6 EIA kit |  | | | VAN DAMME J., OPDENAKKER G., SIMPSON R-J. et al. | | | Identification of the human 26-kD protein, interferon β2 (IFN-β2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin-1 and tumor necrosis factor. J. Exp. Med. 165, 914-919 (1987). |
|  | | | VAN DAMME J., OPDENAKKER G., SIMPSON R-J. et | | | The essential role of B cell stimulatory factor 2 (BSL-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167, 332-344 (1988). |
|  | | | TOSATO G., SEAMON K-B., GOLDMAN N.D. et al. | | | Monocyte-derived human B-cell growth factor identified as interferon-β2 (BSF-2/IL-6). Science. 239, 502-504 (1988). |
|  | | | WONG G-G. & CLARK S-C. | | | Multiple actions of interleukin-6 within a cytokine network. Immunology Today. 9, 137-139 (1988). |
|  | | | KISHIMOTO T. | | | The biology of interleukin-6. Blood 74, 1-10 (1989). |
|  | | | HIRANO T., AKIRA S., TAGA T. et al. | | | Biological and clinical aspects of interleukin 6. Immunol. Today 11, 443-449 (1990). |
|  | | | GRASSI J., ROBERGE C-J., FROBERT Y. et al. | | | Determination of IL1α, IL1β and IL2 in biological media using specific enzyme immunometric assays. Immunol. Rev. 119, 125-145 (1991). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
|  | | | MIHARA M., MORIYA Y., KISHIMOTO T. et al. | | | Interleukin-6 (IL-6) induces the proliferation of synovial fibroplastic cells in the presence of soluble IL-6 receptor. Br. J. Rheumatol. 34, 321-325 (1995). |
| | [top] |  |
| | 583751 - Substance P EIA kit |  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays.J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 585000 - sPLA2 (human synovial) EIA kit |  | | | GRASSI J., ROBERGE C-J., FROBERT Y. et al. | | | Determination of IL1α, IL1β and IL2 in biological media using specific enzyme immunometric assays. Immunol. Rev. 119, 125-145 (1991). |
|  | | | DENNIS E-A. | | | The growing phospholipase A2 superfamily of signal transduction enzymes. Trends Biochem. Sci. 22, 1-2 (1997). |
|  | | | TISCHFIELD J-A. | | | A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem. 272, 17247-17250 (1997). |
| | [top] |  |
| | 589201 - TNF-α(human) EIA kit |  | | | BEUTLER B., GREENWALD D., HULMES J-D. et al. | | | Identify of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature. 316, 552-554 (1985). |
|  | | | TRACEY K-J., BEUTLER B., LOWRY S-F. et al. | | | Shock and tissue injury induced by recombinant human cachectin. Science. 234, 470-474 (1986). |
|  | | | POBER J-S., LAPIERRE L-A., STOLPEN A-H. et al. | | | Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J. Immunol. 138, 3319-3324 (1987). |
|  | | | BROUDY V-C., HARLAN J-M. & ADAMSON J-W. | | | Disparate effects of tumor necrosis factor-α/cachectin and tumor necrosis factor-β/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells. J. Immunol. 138, 4298-4302 (1987). |
|  | | | GRASSI J., ROBERGE C-J., FROBERT Y. et al. | | | Determination of IL1α, IL1β and IL2 in biological media using specific enzyme immunometric assays. Immunol. Rev. 119, 125-145 (1991). |
|  | | | VASSALLI P. | | | The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411-452 (1992). |
|  | | | MAXEY K-M., MADDIPATI K-R. & BIRKMEIER J. | | | Interference in Enzyme Immunoassays. J. Clin. Immunoassay. 15, 116-120 (1992). |
| | [top] |  |
| | 660951 - cDNA Synthesis kit |  | | | KOTEWICZ M-L., D'ALESSIO J-M., DRIFTNIER K-M., BLODGETT K-P. & GERARD G-F. | | | Identify of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature. 316, 552-554 (1985). |
|  | | | GERARD G-F., D'ALESSIO J-M., KOTEWICZ M-L. & NOON M-C. | | | Influence on stability in Escherichia coli of the carboxy-terminal structure of Moloney murine leukemia virus reverse transcriptase. DNA 5, 271-279 (1986). |
|  | | | RAPPOLLEE D-A., MARK D., BANDA M-J. & WEB Z. | | | Would macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 241, 708 (1988). |
|  | | | CHELLEY J., KAPLAN J-C., MAIRE P., GAUTRON S., KAHN A. | | | Transcription of dystrophin gene in human muscle and non-muscle tissues. Nature 333, 858-860 (1988). |
|  | | | NOONAN E. & RONINSON I.B. | | | TI: mRNA phenotyping by enzymatic amplification of randomly primed cDNA. Nucl. Acids Res. 16, 10366 (1988). |
|  | | | SAMBROOK J., FRITSCH E-F. & MANIATIS T. | | | Photooxidative stress in plants. Molecular Cloning: A laboratory Manual, 2ed, Volume 1, Cold Spring Harbor Laboratory (1989). |
| | [top] |  |
| | 703002 - Glutathione Assay kit |  | | | TIETZE F. | | | Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522 (1969). |
|  | | | ARIAS I-M. & JAKOBY W-B. | | | Glutathione: metabolism and function. Editors. Raven Press, New York (1976). |
|  | | | GRIFFITH O-W. | | | Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207-212 (1980). |
|  | | | WENDEL A. & CIKRYT P. | | | The level and half-life of glutathione in human plasma. FEBS Lett. 120, 209-211 (1980). |
|  | | | INOUE, M. | | | Interorgan metabolism and membrane transport of glutathione and related compounds. Chapter 6 in Real Biochemistry. Kinne, R.K.H. editor. Elsevier Science Publishers B.V. London, 225-269 (1985). |
|  | | | LASH L.H. & JONES D-P. | | | Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasma. Arch. Biochem. Biophys. 240, 583-592 (1985). |
|  | | | EYER P. & PODHRADSKY D. | | | Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent. Anal. Biochem.153, 57-66 (1986). |
|  | | | INOUE M., SAITO Y., HIRATA E. et al. | | | Regulation of redox states of plasma proteins by metabolism and transport of glutathione and related compounds. Journal of Protein Chemistry 6, 207-225 (1987). |
|  | | | BAKER M-A., CERNIGLIA G-J., ZAMAN A. | | | Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal. Biochem. 190, 360-365 (1990). |
|  | | | BAILLIE T-A. & SLATTER J-G. | | | Glutathione: a vehicle for the transport of chemically reactive metabolites in vivo. Acc. Chem. Res. 24, 264-270 (1991). |
|  | | | FOYER C-H., LELANDAIS M., KUNERT K-J. | | | Photooxidative stress in plants. Physiol. Plant. 92, 696-717 (1994). |
| | [top] |  |
| | 705002 - Lipid Hydroperoxide (LPO) Assay kit |  | | | BLIGH E-G. & DYER W-J. | | | A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917 (1959). |
|  | | | DICZFALUSY U., FALARDEAU P. & HAMMARSTR[O]M S. | | | Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett. 84, 271-274 (1977). |
|  | | | WARSO M-A. & LANDS W.E.M. | | | Pathophysiological modulation of arachidonate metabolism. Clin. Physiol. Biochem. 2, 70-74 (1984). |
|  | | | CROSS C-E., HALLIWELL B., BORISH E-T. et al. | | | Oxygen radicals and human disease. Ann. Int. Med. 107, 526-545 (1987). |
|  | | | YAMAMOTO Y., BRODSKY M-H., BAKER J-C. et al. | | | Detection and characterization of lipid hydroperoxides at picomole levels by high-performance liquid chromatography. Anal. Biochem. 160, 7-13 (1987). |
|  | | | PRYOR W-A. & PORTER N-A. | | | Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyinsaturated fatty acids. Free Radic. Biol. Med. 8, 541-543 (1990). |
|  | | | JANERO D-R. | | | Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9, 515-540 (1990). |
|  | | | ESTERBAUER H., SCHAUR R-J. & ZOLINER H. | | | Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128 (1991). |
|  | | | PORTER N-A., MILLS K-A. & CALDWELL S-E. | | | Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 30, 277-290 (1995). |
|  | | | HALLIWELL B. | | | Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in human. Free Rad. Res. 25, 57-74 (1996). |
|  | | | MIHALJEVIC B., KATUSIN-RAZEM B. & RAZEM. | | | The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanism aspects of the response. Free Radic. Biol. Med. 21, 53-63 (1996). |
|  | | | HOFFMAN S-W., ROOF R-L. & STEIN D-G. | | | A reliable and sensitive enzyme immunoassay method for measuring 8-isoprostaglandin F2α : a marker for lipid peroxidation after experimental brain injury. J. Neurosci. Methods 68, 133-136 (1996). |
|  | | | MORROW J.D. & ROBERTS L-J. | | | The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36, 1-21 (1997). |
| | [top] |  |
| | 760700 - Lipoxygenase Inhibitor Screening Assay kit |  | | | YAMAMOTO S. | | | Mammalian lipoxygenases: molecular structures and functions. Biochim. Biophys. Acta 1128, 117-131 (1992). |
|  | | | GAFFNEY B-J. | | | Lipoxygenases: structural principles and spectroscopy. Annu. Rev. Biophys. Biomol. Struct. 25, 431-459 (1996). |
| | [top] |  |
| | 760871 - Nitrate/Nitrite Colorimetric Assay Kit (LDH method) |  | | | GREEN L-C., WAGNER D-A., GLOGOWSKI J. et al. | | | Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138 (1982). |
|  | | | MONCADA S. | | | The L-arginine: nitric oxide pathway. Acta Physiol. Scand. 145, 201-227 (1992). |
|  | | | NATHAN C. | | | Nitric oxide as a secretory product of mammalian cells. FASEB Journal. 6, 3051-3064 (1992). |
|  | | | NIMS R-W., DARBYSHIRE J-F., SAAVEDRA J-E. et al. | | | Colorimetric methods for the determination of nitric oxide concentration in neutral aqueous solutions. Methods. 7, 48-54 (1995). |
| | [top] |  |
| | 760901 - PAF Acetylhydrolase Assay kit |  | | | STAFFORINI D-M., PRESCOTT S-M., MCINTYRE T-M. | | | Human plasma platelet-activating factor acetylhydrolase. J. Biol. Chem. 262, 4223-4230 (1987). |
|  | | | AARSMAN A-J., NEYS F-W. & VAN DER BOSCH H. | | | Catabolism of platelet-activating factor and its acyl analog. Differentiation of the activities of lysophospholipase and platelet-activating-factor acetylhydrolase. Eur. J. Biochem. 200, 187-193 (1991). |
|  | | | STEWART A-G. & GRIGORIADIS G. | | | Structure-activity relationships for platelet-activating factor (PAF) and analogs reveal differences between PAF receptors on platelets and macrophages. J. Lipid Mediators. 4, 299-308 (1991). |
|  | | | NARAHARA H., NISHIOKA Y., JOHNSTON J-M. | | | Secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. J. Clin. Endocrinol. Metab. 77, 1258-1262 (1993). |
| | [top] |  |
| | 765001 - sPhospholipase A2 Assay kit |  | | | DENNIS E-A. | | | Phospholipases. Enzymes. XVI, 307-353 (1983). |
|  | | | HENDRICKSON H-S., KENDRICKSON E-K. & DYBVIG R-H. | | | Chiral synthesis of a dithiolester analog of phosphatidylcholine as a substrate for the assay of phospholipase A2. J. Lipid Res. 24, 1532-1537 (1983). |
|  | | | REYNOLDS L-J., HUGHES L-L. & DENNIS E-A. | | | Analysis of human synovial fluid phospholipase A2 on short chain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a microtiterplate reader. Anal. Biochem. 204, 190-197 (1992). |
|  | | | DENNIS E-A. | | | Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269, 13057-13060 (1994). |
| | [top] |  |
| | 765021 - Cytosolic Phospholipase A2 Assay kit |  | | | DENNIS E-A. | | | in The Enzymes. Boyer 3rd ed., Vol. 16, pp. 307-353, Academic Press, New York (1983). |
|  | | | YU L., DEEMS R-A., HAJDU J. et al. | | | The interaction of phospholipase A2 with phospholipid analogues and inhibitors. J. Biol. Chem. 265, 2657-2664 (1990). |
|  | | | Hazen S-L., Zupan L-A., Weiss R-H. et al. | | | Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. J. Biol. Chem. 266, 7227-7232 (1991). |
|  | | | PLESNIAK L-A., BOEGEMAN S-C., SEGELKE B-W. et al. | | | Interaction of phospholipase A2 with thioether amide containing phospholipid analogues. Biochemistry, 32, 5009-5016 (1993). |
|  | | | REYNOLDS L-J., HUGHES L-L., YU L. et al. | | | 1-Hexadecyl-2-arachidonoylthio-2-deoxy-sn-glycero-3-phosphorylcholine as a substrate for the microtiterplate assay of human cytosolic phospholipase A2. Anal. Biochem. 217, 25-32 (1994). |
|  | | | DENNIS E-A. | | | Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269, 13057-13060 (1994). |
|  | | | ACKERMANN E-J., CONDE-FRIEBOES K. & DENNIS E-A. | | | Inhibition of macrophage Ca 2+-independent phospholipase A2 by bromoenol lactone and trifluoromethyl ketones. J. Biol. Chem. 270, 445-450 (1995). |
|  | | | BALSINDE J., BIANCO I-D., ACKERMANN E-J. et al. | | | Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc. Natl. Acad. Sci. USA 92, 8527-8531 (1995). |
|  | | | REDDY S-T. & HERSCHMAN H-R. | | | Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells. J. Biol. Chem. 272, 3231-3237 (1997). |
| | [top] |  |
| | 780001 - Nitrate/Nitrite Colorimetric Assay kit |  | | | GREEN L-C., WAGNER D-A., GLOGOWSKI J. et al. | | | Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138 (1982). |
|  | | | MONCADA S. | | | The L-arginine: nitric oxide pathway. Acta Physiol. Scand. 145, 201-227 (1992). |
|  | | | NATHAN C. | | | Nitric oxide as a secretory product of mammalian cells. FASEB Journal. 6, 3051-3064 (1992). |
|  | | | NIMS R-W., DARBYSHIRE J-F., SAAVEDRA J-E. et al.. | | | Colorimetric methods for the determination of nitric oxide concentration in neutral aqueous solutions. Methods. 7, 48-54 (1995). |
| | [top] |  |
| | 780051 - Nitrate/Nitrite Fluorimetric Assay kit |  | | | GREEN L-C., WAGNER D-A., GLOGOWSKI J. et al. | | | Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138 (1982). |
|  | | | MONCADA S. | | | The L-arginine: nitric oxide pathway. Acta Physiol. Scand. 145, 201-227 (1992). |
|  | | | NATHAN C. | | | Nitric oxide as a secretory product of mammalian cells. FASEB Journal. 6, 3051-3064 (1992). |
|  | | | MISKO T-P., SCHILLING R-J., SALVEMINI D. et al | | | A fluorimetric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214, 11-16 (1993). |
|  | | | MILES A-M., CHEN Y., OWENS M-W. et al. | | | Fluorimetric determination of nitric oxide. Methods. 7, 40-47 (1995). |
| | [top] |  |
| | 781001 - NOS Assay kit |  | | | KNOWLES R-G., PALACIOS M., PALMER R-M. et al. | | | Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Sci. USA 86, 5159-5162 (1989). |
|  | | | BREDT D-S. & SNYDER S-H. | | | Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Sci. USA 87, 682-685 (1990). |
|  | | | SALTER M., KNOWLES R-G. & MONCADA S. | | | Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent nitric oxide synthases. FEBS Lett. 291, 145-149 (1991). |
|  | | | STUEHR D-J., CHO H-J., KWON N-S. et al. | | | Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein. Proc. Natl. Sci. USA 88, 7773-7777 (1991). |
|  | | | SCHMIDT H-H., POLLOCK J-S., NAKANE M. et al. | | | Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc. Natl. Sci. USA 88, 365-369 (1991). |
|  | | | POLLOCK J-S., FORSTERMANN U., MITCHELL J-A. et al. | | | Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Sci. USA 88, 10480-10484 (1991). |
|  | | | IGNARRO L-J. | | | Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41, 485-90 (1991). |
|  | | | MARLETTA M-A. | | | Nitric oxide synthase structure and mecanism. J. Biol. Chem. 268, 12231-12234 (1993). |
|  | | | MONCADA S. & HIGGS A-N. | | | The L-arginine-nitric oxide pathway Engl. J. Med. 329, 2002-2012 (1993). |
|  | | | SCHMIDT H-H., LOHMANN S-M. & WALTER U. | | | The nitric oxide and cGMP signal transduction system: regulation and mecanism of action. Biochim. Biophys. Acta 1178, 153-175 (1993). |
|  | | | BUSCONI L. & MICHEL T. | | | Endothelial nitric oxide synthase. N-terminal myristoylation determines subcellular localization. J. Biol. Chem. 268, 8410-8413 (1993). |
|  | | | BREDT D-S. & SNYDER S-H. | | | Nitric Oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63, 175-195 (1994). |
|  | | | NATHAN C. & XIE Q-W. | | | Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269, 13725-13728 (1994). |
|  | | | KOBZIK L., REID M-B., BREDT D-S. et al. | | | Nitric oxide in skeleton muscles. Nature. 372, 546-548 (1994). |
| | [top] |  |
| | | Back to Scientific Section Page | |
|
|  |
|
|